Not logged in.png)
Share.png)
SaveShare Save Share Save Share Save Share Save Share Save Phase II randomized trial comparing metronomic anthracycline-containing chemotherapy versus standard schedule in untreated HER2 negative advanced breast cancer: activity and quality of life results of the GOIM 21003 trial
Orlando, Laura; Maiello, Evaristo; Orditura, Michele; Diana, Anna; Antoniol, Giuliano; Morritti, Maria Grazia; Aieta, Michele; Ciccarese, Mariangela; Pisconti, Salvatore; Bordonaro, Roberto; Russo, Antonio; Febbraro, Antonio; Schiavone, Paola; Quaranta, Annamaria; Caliolo, Chiara; Loparco, Dario; Cinefra, Margherita; Colucci, Giuseppe; Cinieri, Saverio Share Save Share Save Share Save Share Save Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor PrognosisIovino, Francesco; Diana, Anna; Carlino, Francesca; Ferraraccio, Franca; Antoniol, Giuliano; Fisone, Francesca; Perrone, Alessandra; Zito Marino, Federica; Panarese, Iacopo; Tathode, Madhura S.; Caraglia, Michele; Gatta, Gianluca; Ruggiero, Roberto; Parisi, Simona; De Vita, Ferdinando; Ciardiello, Fortunato; Docimo, Ludovico; Orditura, Michele Share Save Share Save Share Save Prognostic Relevance of Progesterone Receptor Levels in Early Luminal-Like HER2 Negative Breast Cancer Subtypes: A Retrospective AnalysisDiana, Anna; Carlino, Francesca; Buono, Giuseppe; Antoniol, Giuliano; Famiglietti, Vincenzo; De Angelis, Carmine; Carrano, Simone; Piccolo, Antonio; De Vita, Ferdinando; Ciardiello, Fortunato; Daniele, Bruno; Arpino, Grazia; Orditura, Michele Share Save Share Save Share Save Share Save Share Save Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
